Suraksha Diagnostic Limited (BOM:544293)

India · Delayed Price · Currency is INR

260.55

+3.00 (1.16%)

At close: Jul 21, 2026

-18.54% (1Y)

Market Cap	13.44B -19.3%
Revenue (ttm)	3.10B +23.1%
Net Income	321.87M +1.1%
EPS	6.18 +3.5%
Shares Out	n/a
PE Ratio	41.76
Forward PE	33.44
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,014
Open	259.55
Previous Close	257.55
Day's Range	258.15 - 264.95
52-Week Range	224.10 - 333.65
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 5, 2026

About Suraksha Diagnostic

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company al... [Read more]

Industry Medical Laboratories

Founded 1992

Employees 1,300

Stock Exchange Bombay Stock Exchange

Ticker Symbol 544293

Full Company Profile

Financial Performance

In fiscal year 2026, Suraksha Diagnostic's revenue was 3.10 billion, an increase of 23.13% compared to the previous year's 2.52 billion. Earnings were 321.87 million, an increase of 1.14%.

Financial Statements